Phacilitate Leaders Forum

17th - 18th SEPTEMBER 2019



Farzin  Farzaneh

Farzin Farzaneh

Head of Molecular Medicine, Kings College London

Farzin Farzaneh, Professor of Molecular Medicine, Kings College London Having studied at universities of Aberdeen and Sussex, followed by a number of fellowships by Beit, EMBO and MRC, in UK and Holland, I Joined King's College London in 1985. I was appointed the founding head of the Department of Molecular Medicine in 1993. Was awarded a Personal Chair in Molecular Medicine in1996, elected to the Fellowship of the Royal College of Pathologists and to the Royal Society for the Encouragement of Arts, Manufacture & Commerce in 1997, and the Society of Biology in 2011. Having been a co-founder of the International Society for Cell and Gene Therapy of Cancer (ISCGT), I have served as its Secretary General 2001-2006, and its President 2007- 2008. I have published over 200 scientific papers and two edited books on the Functional Analysis of the Genome and Cancer Gene Therapy. I have also established and served as the director of a GMP facility at King’s College Hospital London since 2001, producing Investigational Medicinal Products (IMP) for cell, gene therapy and regenerative medicine clinical studies. I have been the European Editor for Experimental Biology and Medicine since 2006 and on the editorial and advisory boards of a number of other journals and biotechnology companies. Current research interests include the functional analysis of the genome, the study of immune biology of cancer and development of cancer immune therapy.

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd